Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis
•Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking, e-cigarette, and dual use compared to survivors of non-tobacco related cancers.•There was a sequential increase in cigarette use during each subsequent year from the time of a new cancer diagnosis.•There rem...
Gespeichert in:
| Veröffentlicht in: | Cancer epidemiology 2022-06, Vol.78, p.101913, Article 101913 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 101913 |
| container_title | Cancer epidemiology |
| container_volume | 78 |
| creator | Bjurlin, Marc A. Basak, Ramsankar Zambrano, Ibardo Schatz, Daniel El Shahawy, Omar Sherman, Scott Matulewicz, Richard S. |
| description | •Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking, e-cigarette, and dual use compared to survivors of non-tobacco related cancers.•There was a sequential increase in cigarette use during each subsequent year from the time of a new cancer diagnosis.•There remains the need for long term tobacco cessation support among newly diagnosed adults with cancer.
Tobacco-use among cancer survivors leads to preventable morbidity, mortality, and increased healthcare costs. We sought to explore the prevalence of smoking and e-cigarette use among survivors of tobacco and non-tobacco related cancers.
A cross-sectional analysis was conducted using the 2015–2018 National Health Interview Survey. Our primary outcome was the prevalence of current cigarette smoking or e-cigarette use among adults with self-reported history of tobacco related or non-tobacco related cancer. Logistic regression analysis was to assess the association of reported cancer type with cigarette smoking or e-cigarette use. Secondary outcomes included yearly trends and dual use.
A total of 12,984 respondents reported a history of cancer, representing a weighted estimate of 5,060,059 individuals with a history of tobacco-related malignancy and 17,583,788 with a history of a tobacco and non-tobacco related cancer, respectively. Survivors of tobacco-related cancers had a significantly higher prevalence of current cigarette use (18.2 % vs 9.7 %, P |
| doi_str_mv | 10.1016/j.canep.2021.101913 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2665566732</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1877782121000308</els_id><sourcerecordid>2665566732</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-16198212876019624b280d3801a089daf2fe7a8c09455b678ecc3452473317333</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxiNERUvhCZCQJS5csvhPYjtIHKoKClKlcgCJm-V1JpWXJF48yUr7an06ZrNtDz30YNka_74Z-_uK4p3gK8GF_rRZBT_CdiW5FIdKI9SL4kxYY0pj1Z-Xj2cpTovXiBvOtRaiflWcKqVNJStzVtz99NMEeUTmx5Z5xBSin2KiQuoYDulvHG-XO-ghTDmNMbAQb30G0rEZgfkhEYJz3sVdyotuSmsfQmIZej9Bu-jHNJZP6_SBABk_sws2LlN93-_pdpsBYZyotAMWckIskaYvADXz_R4jvilOOt8jvL3fz4vf377-uvxeXt9c_bi8uC6DsmYqhRYNWSCt0eSRltVaWt4qy4Xntml9Jzsw3gbeVHW91sZCCKqqyR2lBC11Xnw89t3m9G8GnNwQMUDfk_tpRierxlbGGlER-uEJuklzpvcSpXVda22UJEodqeVnGTq3zXHwee8Ed4do3cYt0bpDtO4YLane3_ee1wO0j5qHLAn4cgSAzNhFyA5DBDK4jZnMc22Kzw74D7wKuJk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2665566732</pqid></control><display><type>article</type><title>Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Bjurlin, Marc A. ; Basak, Ramsankar ; Zambrano, Ibardo ; Schatz, Daniel ; El Shahawy, Omar ; Sherman, Scott ; Matulewicz, Richard S.</creator><creatorcontrib>Bjurlin, Marc A. ; Basak, Ramsankar ; Zambrano, Ibardo ; Schatz, Daniel ; El Shahawy, Omar ; Sherman, Scott ; Matulewicz, Richard S.</creatorcontrib><description>•Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking, e-cigarette, and dual use compared to survivors of non-tobacco related cancers.•There was a sequential increase in cigarette use during each subsequent year from the time of a new cancer diagnosis.•There remains the need for long term tobacco cessation support among newly diagnosed adults with cancer.
Tobacco-use among cancer survivors leads to preventable morbidity, mortality, and increased healthcare costs. We sought to explore the prevalence of smoking and e-cigarette use among survivors of tobacco and non-tobacco related cancers.
A cross-sectional analysis was conducted using the 2015–2018 National Health Interview Survey. Our primary outcome was the prevalence of current cigarette smoking or e-cigarette use among adults with self-reported history of tobacco related or non-tobacco related cancer. Logistic regression analysis was to assess the association of reported cancer type with cigarette smoking or e-cigarette use. Secondary outcomes included yearly trends and dual use.
A total of 12,984 respondents reported a history of cancer, representing a weighted estimate of 5,060,059 individuals with a history of tobacco-related malignancy and 17,583,788 with a history of a tobacco and non-tobacco related cancer, respectively. Survivors of tobacco-related cancers had a significantly higher prevalence of current cigarette use (18.2 % vs 9.7 %, P < 0.0001), e-cigarette use (2.7 % vs 1.6 %, P < 0.0001) and similar rates of dual use. The prevalence of cigarette smoking among all survivors increased as time increased from the year of diagnosis up to 2 years post-diagnosis (P = 0.047). Odds of reporting current cigarette smoking use was higher for survivors of tobacco-related cancers, adjusted for sociodemographic factors (OR1.69, 95 % CI 1.44−1.99).
Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking and e-cigarette use compared to survivors of non-tobacco related cancers. There was a sequential increase in the prevalence of cigarette use during each subsequent year from the time of a new cancer diagnosis, underscoring the need for long term tobacco cessation support among newly diagnosed adults with cancer.</description><identifier>ISSN: 1877-7821</identifier><identifier>ISSN: 1877-783X</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2021.101913</identifier><identifier>PMID: 33674247</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Adults ; Age ; Cancer ; Cancer Survivors ; Cancer therapies ; Cigarette smoking ; Cross-Sectional Studies ; Data collection ; Diagnosis ; Electronic cigarettes ; Electronic Nicotine Delivery Systems ; Epidemiology ; Ethnicity ; Health care ; Humans ; Malignancy ; Medical diagnosis ; Melanoma ; Morbidity ; Neoplasms - epidemiology ; Neoplasms - pathology ; Persistent cigarette smoking ; Population ; Prevalence ; Regression analysis ; Smoking ; Smoking Cessation ; Sociodemographics ; Survival ; Tobacco ; Tobacco Products ; Tobacco related and non-tobacco related cancers ; Trends ; Vaping ; Vaping - adverse effects ; Vaping - epidemiology</subject><ispartof>Cancer epidemiology, 2022-06, Vol.78, p.101913, Article 101913</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><rights>2021. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-16198212876019624b280d3801a089daf2fe7a8c09455b678ecc3452473317333</citedby><cites>FETCH-LOGICAL-c387t-16198212876019624b280d3801a089daf2fe7a8c09455b678ecc3452473317333</cites><orcidid>0000-0003-3342-6377 ; 0000-0003-4384-0969 ; 0000-0003-1752-7303</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1877782121000308$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33674247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bjurlin, Marc A.</creatorcontrib><creatorcontrib>Basak, Ramsankar</creatorcontrib><creatorcontrib>Zambrano, Ibardo</creatorcontrib><creatorcontrib>Schatz, Daniel</creatorcontrib><creatorcontrib>El Shahawy, Omar</creatorcontrib><creatorcontrib>Sherman, Scott</creatorcontrib><creatorcontrib>Matulewicz, Richard S.</creatorcontrib><title>Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis</title><title>Cancer epidemiology</title><addtitle>Cancer Epidemiol</addtitle><description>•Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking, e-cigarette, and dual use compared to survivors of non-tobacco related cancers.•There was a sequential increase in cigarette use during each subsequent year from the time of a new cancer diagnosis.•There remains the need for long term tobacco cessation support among newly diagnosed adults with cancer.
Tobacco-use among cancer survivors leads to preventable morbidity, mortality, and increased healthcare costs. We sought to explore the prevalence of smoking and e-cigarette use among survivors of tobacco and non-tobacco related cancers.
A cross-sectional analysis was conducted using the 2015–2018 National Health Interview Survey. Our primary outcome was the prevalence of current cigarette smoking or e-cigarette use among adults with self-reported history of tobacco related or non-tobacco related cancer. Logistic regression analysis was to assess the association of reported cancer type with cigarette smoking or e-cigarette use. Secondary outcomes included yearly trends and dual use.
A total of 12,984 respondents reported a history of cancer, representing a weighted estimate of 5,060,059 individuals with a history of tobacco-related malignancy and 17,583,788 with a history of a tobacco and non-tobacco related cancer, respectively. Survivors of tobacco-related cancers had a significantly higher prevalence of current cigarette use (18.2 % vs 9.7 %, P < 0.0001), e-cigarette use (2.7 % vs 1.6 %, P < 0.0001) and similar rates of dual use. The prevalence of cigarette smoking among all survivors increased as time increased from the year of diagnosis up to 2 years post-diagnosis (P = 0.047). Odds of reporting current cigarette smoking use was higher for survivors of tobacco-related cancers, adjusted for sociodemographic factors (OR1.69, 95 % CI 1.44−1.99).
Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking and e-cigarette use compared to survivors of non-tobacco related cancers. There was a sequential increase in the prevalence of cigarette use during each subsequent year from the time of a new cancer diagnosis, underscoring the need for long term tobacco cessation support among newly diagnosed adults with cancer.</description><subject>Adult</subject><subject>Adults</subject><subject>Age</subject><subject>Cancer</subject><subject>Cancer Survivors</subject><subject>Cancer therapies</subject><subject>Cigarette smoking</subject><subject>Cross-Sectional Studies</subject><subject>Data collection</subject><subject>Diagnosis</subject><subject>Electronic cigarettes</subject><subject>Electronic Nicotine Delivery Systems</subject><subject>Epidemiology</subject><subject>Ethnicity</subject><subject>Health care</subject><subject>Humans</subject><subject>Malignancy</subject><subject>Medical diagnosis</subject><subject>Melanoma</subject><subject>Morbidity</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - pathology</subject><subject>Persistent cigarette smoking</subject><subject>Population</subject><subject>Prevalence</subject><subject>Regression analysis</subject><subject>Smoking</subject><subject>Smoking Cessation</subject><subject>Sociodemographics</subject><subject>Survival</subject><subject>Tobacco</subject><subject>Tobacco Products</subject><subject>Tobacco related and non-tobacco related cancers</subject><subject>Trends</subject><subject>Vaping</subject><subject>Vaping - adverse effects</subject><subject>Vaping - epidemiology</subject><issn>1877-7821</issn><issn>1877-783X</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kc9u1DAQxiNERUvhCZCQJS5csvhPYjtIHKoKClKlcgCJm-V1JpWXJF48yUr7an06ZrNtDz30YNka_74Z-_uK4p3gK8GF_rRZBT_CdiW5FIdKI9SL4kxYY0pj1Z-Xj2cpTovXiBvOtRaiflWcKqVNJStzVtz99NMEeUTmx5Z5xBSin2KiQuoYDulvHG-XO-ghTDmNMbAQb30G0rEZgfkhEYJz3sVdyotuSmsfQmIZej9Bu-jHNJZP6_SBABk_sws2LlN93-_pdpsBYZyotAMWckIskaYvADXz_R4jvilOOt8jvL3fz4vf377-uvxeXt9c_bi8uC6DsmYqhRYNWSCt0eSRltVaWt4qy4Xntml9Jzsw3gbeVHW91sZCCKqqyR2lBC11Xnw89t3m9G8GnNwQMUDfk_tpRierxlbGGlER-uEJuklzpvcSpXVda22UJEodqeVnGTq3zXHwee8Ed4do3cYt0bpDtO4YLane3_ee1wO0j5qHLAn4cgSAzNhFyA5DBDK4jZnMc22Kzw74D7wKuJk</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Bjurlin, Marc A.</creator><creator>Basak, Ramsankar</creator><creator>Zambrano, Ibardo</creator><creator>Schatz, Daniel</creator><creator>El Shahawy, Omar</creator><creator>Sherman, Scott</creator><creator>Matulewicz, Richard S.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3342-6377</orcidid><orcidid>https://orcid.org/0000-0003-4384-0969</orcidid><orcidid>https://orcid.org/0000-0003-1752-7303</orcidid></search><sort><creationdate>202206</creationdate><title>Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis</title><author>Bjurlin, Marc A. ; Basak, Ramsankar ; Zambrano, Ibardo ; Schatz, Daniel ; El Shahawy, Omar ; Sherman, Scott ; Matulewicz, Richard S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-16198212876019624b280d3801a089daf2fe7a8c09455b678ecc3452473317333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Age</topic><topic>Cancer</topic><topic>Cancer Survivors</topic><topic>Cancer therapies</topic><topic>Cigarette smoking</topic><topic>Cross-Sectional Studies</topic><topic>Data collection</topic><topic>Diagnosis</topic><topic>Electronic cigarettes</topic><topic>Electronic Nicotine Delivery Systems</topic><topic>Epidemiology</topic><topic>Ethnicity</topic><topic>Health care</topic><topic>Humans</topic><topic>Malignancy</topic><topic>Medical diagnosis</topic><topic>Melanoma</topic><topic>Morbidity</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - pathology</topic><topic>Persistent cigarette smoking</topic><topic>Population</topic><topic>Prevalence</topic><topic>Regression analysis</topic><topic>Smoking</topic><topic>Smoking Cessation</topic><topic>Sociodemographics</topic><topic>Survival</topic><topic>Tobacco</topic><topic>Tobacco Products</topic><topic>Tobacco related and non-tobacco related cancers</topic><topic>Trends</topic><topic>Vaping</topic><topic>Vaping - adverse effects</topic><topic>Vaping - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bjurlin, Marc A.</creatorcontrib><creatorcontrib>Basak, Ramsankar</creatorcontrib><creatorcontrib>Zambrano, Ibardo</creatorcontrib><creatorcontrib>Schatz, Daniel</creatorcontrib><creatorcontrib>El Shahawy, Omar</creatorcontrib><creatorcontrib>Sherman, Scott</creatorcontrib><creatorcontrib>Matulewicz, Richard S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bjurlin, Marc A.</au><au>Basak, Ramsankar</au><au>Zambrano, Ibardo</au><au>Schatz, Daniel</au><au>El Shahawy, Omar</au><au>Sherman, Scott</au><au>Matulewicz, Richard S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis</atitle><jtitle>Cancer epidemiology</jtitle><addtitle>Cancer Epidemiol</addtitle><date>2022-06</date><risdate>2022</risdate><volume>78</volume><spage>101913</spage><pages>101913-</pages><artnum>101913</artnum><issn>1877-7821</issn><issn>1877-783X</issn><eissn>1877-783X</eissn><abstract>•Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking, e-cigarette, and dual use compared to survivors of non-tobacco related cancers.•There was a sequential increase in cigarette use during each subsequent year from the time of a new cancer diagnosis.•There remains the need for long term tobacco cessation support among newly diagnosed adults with cancer.
Tobacco-use among cancer survivors leads to preventable morbidity, mortality, and increased healthcare costs. We sought to explore the prevalence of smoking and e-cigarette use among survivors of tobacco and non-tobacco related cancers.
A cross-sectional analysis was conducted using the 2015–2018 National Health Interview Survey. Our primary outcome was the prevalence of current cigarette smoking or e-cigarette use among adults with self-reported history of tobacco related or non-tobacco related cancer. Logistic regression analysis was to assess the association of reported cancer type with cigarette smoking or e-cigarette use. Secondary outcomes included yearly trends and dual use.
A total of 12,984 respondents reported a history of cancer, representing a weighted estimate of 5,060,059 individuals with a history of tobacco-related malignancy and 17,583,788 with a history of a tobacco and non-tobacco related cancer, respectively. Survivors of tobacco-related cancers had a significantly higher prevalence of current cigarette use (18.2 % vs 9.7 %, P < 0.0001), e-cigarette use (2.7 % vs 1.6 %, P < 0.0001) and similar rates of dual use. The prevalence of cigarette smoking among all survivors increased as time increased from the year of diagnosis up to 2 years post-diagnosis (P = 0.047). Odds of reporting current cigarette smoking use was higher for survivors of tobacco-related cancers, adjusted for sociodemographic factors (OR1.69, 95 % CI 1.44−1.99).
Survivors of tobacco-related cancers have a higher prevalence of current cigarette smoking and e-cigarette use compared to survivors of non-tobacco related cancers. There was a sequential increase in the prevalence of cigarette use during each subsequent year from the time of a new cancer diagnosis, underscoring the need for long term tobacco cessation support among newly diagnosed adults with cancer.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33674247</pmid><doi>10.1016/j.canep.2021.101913</doi><orcidid>https://orcid.org/0000-0003-3342-6377</orcidid><orcidid>https://orcid.org/0000-0003-4384-0969</orcidid><orcidid>https://orcid.org/0000-0003-1752-7303</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1877-7821 |
| ispartof | Cancer epidemiology, 2022-06, Vol.78, p.101913, Article 101913 |
| issn | 1877-7821 1877-783X 1877-783X |
| language | eng |
| recordid | cdi_proquest_journals_2665566732 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Adults Age Cancer Cancer Survivors Cancer therapies Cigarette smoking Cross-Sectional Studies Data collection Diagnosis Electronic cigarettes Electronic Nicotine Delivery Systems Epidemiology Ethnicity Health care Humans Malignancy Medical diagnosis Melanoma Morbidity Neoplasms - epidemiology Neoplasms - pathology Persistent cigarette smoking Population Prevalence Regression analysis Smoking Smoking Cessation Sociodemographics Survival Tobacco Tobacco Products Tobacco related and non-tobacco related cancers Trends Vaping Vaping - adverse effects Vaping - epidemiology |
| title | Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A00%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patterns%20and%20associations%20of%20smoking%20and%20electronic%20cigarette%20use%20among%20survivors%20of%20tobacco%20related%20and%20non-tobacco%20related%20cancers:%20A%20nationally%20representative%20cross-sectional%20analysis&rft.jtitle=Cancer%20epidemiology&rft.au=Bjurlin,%20Marc%20A.&rft.date=2022-06&rft.volume=78&rft.spage=101913&rft.pages=101913-&rft.artnum=101913&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2021.101913&rft_dat=%3Cproquest_cross%3E2665566732%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2665566732&rft_id=info:pmid/33674247&rft_els_id=S1877782121000308&rfr_iscdi=true |